Monthly Archives: June 2010
Evaluating New Regimens in Recurrent Ovarian Cancer: How Much Evidence Is Good Enough?
Stephen A. Cannistra Beth Israel Deaconess Medical Center, Boston, MA Recurrent ovarian cancer remains a difficult disease to treat. Drugs used in the recurrent disease setting include platinum compounds, taxanes, pegylated liposomal doxorubicin (PLD), gemcitabine, topotecan, pemetrexed, and etoposide. Investigational … Continue reading
Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
Purpose The objective of this study was to compare the efficacy and safety of trabectedin plus pegylated liposomal doxorubicin (PLD) with that of PLD alone in women with recurrent ovarian cancer after failure of first-line, platinum-based chemotherapy. Patients and Methods … Continue reading
“Shielded” ovarian cancer cells may survive chemotherapy
Monday 28 June 2010 Cancer Research UK Press Release “SHIELDED” OVARIAN CANCER CELLS MAY SURVIVE CHEMOTHERAPY TO RE-GROW TUMOUR Cancer Research UK scientists have discovered certain ovarian tumour cells that are resistant to chemotherapy can survive a first round of … Continue reading
Napa-Solano Building Trades Council joins fight against ovarian cancer
On June 14, 2010 the Napa-Solano Building Trades Council held a golf tournament fund raising event at the Rancho Solano Golf Course in Fairfield, California. Lou Franchimon, Business Manager of the Napa-Solano Building Trades Council, decided to host this event … Continue reading
Posted in Blog Leave a comment
Action is Teal – Policy News Update!
Rebate to Medicare Beneficiaries is in the Mail Included in the health reform bill, enacted in March, is a provision that provides Medicare beneficiaries with $250 when they reach the “donut hole.” The first checks were sent out earlier this … Continue reading
Posted in Blog Leave a comment
Jessica Doss: New Lexington, OH
Hello everyone! My name is Jessica and I was first diagnosed with stage 3 ovarian cancer in July of 2008. I was 24 years old. I had gone to the ER because my stomach was hurting so bad. I was … Continue reading
Posted in Personal stories Leave a comment
Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer
BACKGROUND: Most women with advanced epithelial ovarian cancer will ultimately develop recurrent disease after completion of initial treatment with primary surgery and adjuvant chemotherapy. Secondary cytoreductive surgery may have survival benefits in selected patients. However, a number of chemotherapeutic agents … Continue reading
Posted in News Tagged chemotherapy, outcomes, recurrence, Research, surgery, treatment Leave a comment
Mumps and ovarian cancer: modern interpretation of an historic association
BACKGROUND: Epidemiologic studies found childhood mumps might protect against ovarian cancer. To explain this association, we investigated whether mumps might engender immunity to ovarian cancer through antibodies against the cancer-associated antigen MUC1 abnormally expressed in the inflamed parotid gland. METHODS: … Continue reading
Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.
Ovarian cancer has been associated in epidemiologic studies with postmenopausal hormone use. Whether associations differ by hormone regimen, current status or duration of use, is unclear. We examined epithelial ovarian cancer incidence in relation to unopposed estrogen (E-only) and estrogen … Continue reading
Cancer Patients Struggling To Afford Care And Pay Bills In Troubled Economy, According To New Poll
A new poll illustrates the difficulty that cancer patients, survivors and their families face in affording needed health care and paying for other basic necessities such as food and heat, underscoring the need to strongly implement the Affordable Care Act … Continue reading
Hopes Dashed That Vitamin D Reduces Cancer Risk
Researchers did find those with high levels more likely to develop pancreatic cancer ew research appears to dash hopes that people who consume more vitamin D might be at less risk of developing several less-common types of cancer. Researchers found … Continue reading
